S.0 MIKAYE: Hypertension in Pregnancy From Diagnosis to Management
S.0 MIKAYE, Medical Doctor at MSK, shared a post on LinkedIn:
“Hypertension in Pregnancy
Definition: BP higher 140, 90 mmHg during pregnancy. Severe hypertension is higher 160 110 mmHg.
Main types
1. Chronic hypertension, present before pregnancy or diagnosed before 20 weeks.
2. Gestational hypertension, develops after 20 weeks without proteinuria or organ dysfunction.
3. Pre eclampsia, hypertension after 20 weeks with proteinuria and or maternal organ dysfunction.
4. Eclampsia pre eclampsia complicated by seizures.
5. Superimposed pre eclampsia pre eclampsia developing in a woman with chronic hypertension.
Common symptoms of pre eclampsia
- Severe headache
- Blurred vision or visual disturbances
- Epigastric or right upper quadrant pain
- Shortness of breath
- Reduced urine output
- Sudden swelling or weight gain
Assessment
- Repeated BP measurements
- Urine protein assessment
- FBC platelets
- Renal and liver function tests
- Fetal growth and wellbeing assessment
Management
- Monitor mother and fetus closely.
- Pregnancy compatible antihypertensives include labetalol, nifedipine and methyldopa.
- Severe hypertension requires urgent treatment.
- Magnesium sulfate is used for seizure prevention or treatment in severe pre eclampsia eclampsia.
- Definitive treatment is delivery, with timing depending on maternal and fetal condition.
Major complications
Mother: eclampsia, stroke, HELLP syndrome, renal failure, pulmonary oedema, placental abruption.
Baby: fetal growth restriction, prematurity, fetal hypoxia and stillbirth.
BP higher 140,90 after 20 weeks plus proteinuria or organ dysfunction lead to pre eclampsia.”
Stay updated with Hemostasis Today.
-
Nov 11, 2026, 15:42Tareq Abadl: The Clinical Impact of Kell Alloimmunization
-
Nov 11, 2026, 15:30Alejandro González Veliz: Does PCI Change The Long-Term Outcome In Stable Coronary Artery Disease?
-
Nov 11, 2026, 15:25Preparing for the SoHO Regulation – EBA Board Convenes in Vienna – European Blood Alliance
-
Nov 11, 2026, 15:20Vaidehi Prasanth: IV Iron in Heart Failure – Exploring Hospitalisation Benefits vs. Infection Risk in Open Heart
-
Nov 11, 2026, 15:18Stefan Prendić: Can Algorithms Support Antibody Identification in Immunohematology?
-
Nov 11, 2026, 15:12Perioperative Challenges in Hemophilia Patients on Rebalancing Therapies
-
Nov 11, 2026, 15:03Maria Elisa Mancuso: World-Renowned Faculty and 33 Global Participants Unite at Hemophilia Academy 2026
-
Nov 11, 2026, 15:01Hassan Raza: The JAK2 V617F Revolution
-
Nov 11, 2026, 14:57Edward Lee Carter: Factor Xla Inhibition Enters Clinical Practice – FDA Approval of Asundexian